Academic Journal
View in EDS
PDF Full Text

Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases

Bibliographic Details
Title: Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases
Authors: Vikas Gupta, Vikram Kumar Gupta, Navjot Kaur Bajwa, Ashi Sachdeva, Rupali Garg, Abhra Ghosh
Source: Journal of Family Medicine and Primary Care, Vol 13, Iss 5, Pp 1904-1910 (2024)
Publisher Information: Wolters Kluwer Medknow Publications, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: autoimmune rheumatic diseases, covid-19, covishield, Medicine
More Details: Introduction: The Coronavirus disease 2019 (COVID-19) pandemic has been the biggest threat to humankind during the last 3 years. It has caused the loss of more than 6.9 million precious lives across the world. The only method by which the massacre could be stopped was by mass vaccination or mass immunization. The patients suffering from autoimmune rheumatic disorders (AIRDs) and treated with immunosuppressants were the high-priority candidates for vaccination. However, the data regarding the efficacy of COVID-19 vaccines in this group of patients are very less. Hence, this study was planned to study the immunogenicity of Covishield in patients with AIRDs attending the rheumatology OPD at DMCH, Ludhiana. Materials and Methods: It was a prospective cohort study and was planned by the Department of Biochemistry and Department of Clinical Immunology and Rheumatology at Dayanand Medical College and Hospital, Ludhiana. Fifty patients with AIRDs attending the DMCH rheumatology OPD and 52 age and sex-matched healthy controls who had received two doses of Covishield vaccine were included in this study. Patients having any other immunosuppressive conditions like uncontrolled diabetes, hepatitis, malignancy or HIV were excluded. Patients who had suffered from previous laboratory-confirmed COVID-19 infection (by RT-PCR) were also excluded. Blood samples were collected following all aseptic precautions from patients and controls on the 28th day after administration of a second dose of Covishield vaccine and total antibodies to the severe acute respiratory syndrome coronavirus 2 spike (S) protein receptor binding domain was measured using Elecsys Anti-SARS-CoV-2 S kit from Roche. Results: It was observed that no significant difference was there in antibody titre between cases and controls (6213 ± 4418 vs. 8331 ± 7979, P = 0.1022). It was also observed that no statistically significant difference in antibody titre in cases without prednisolone and those taking treatment with prednisolone was found (P = 0.7058). A similar observation was found in terms of methotrexate also (P = 0.457). No significant difference in antibody titres was there when compared with controls (for prednisolone, P = 0.169, for methotrexate, P = 0.078). We found that only the patients receiving mycophenolate mofetil showed a statistically significant decrease in antibody titre in comparison to healthy controls (P = 0.03). Our study showed no statistically significant difference in antibody titres between patients suffering from different AIRDs. Conclusion: Our study supplements the fact that patients with AIRDs in India can receive Covishield as the primary vaccine against COVID-19 without concerns regarding decreased immunogenicity or increased adverse effects.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2249-4863
2278-7135
Relation: https://journals.lww.com/10.4103/jfmpc.jfmpc_1021_23; https://doaj.org/toc/2249-4863; https://doaj.org/toc/2278-7135
DOI: 10.4103/jfmpc.jfmpc_1021_23
Access URL: https://doaj.org/article/f5a878090cb748128719ede264df7c89
Accession Number: edsdoj.f5a878090cb748128719ede264df7c89
Database: Directory of Open Access Journals
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwGUGlnB1NljvdogH4nfeWlFAAAA4TCB3gYJKoZIhvcNAQcGoIHQMIHNAgEAMIHHBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDPz5tSqVXfcSH9utwwIBEICBmR8h8RNP6zy50nDRoxyZSD-UDAMEnGJ4cwdsnZDP54UkYS3Pl66RZEYZu4DAQu825zdyLGhrZWIthsT9xPhTFWBlf0H7Eup4utm7ukL1qwVJLxhFScS7gOSb9UJ_nCs40IPVeUV2VLenkm6n2rZp670zP6KlQlyFAZQQAYBthQi8qphV_HgthPgf1c5SMi9kUgq5PMZQQfHmxQ==
Text:
  Availability: 0
CustomLinks:
  – Url: https://doaj.org/article/f5a878090cb748128719ede264df7c89
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from Directory of Open Access Journals
    MouseOverText: View record from Directory of Open Access Journals
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=22494863&ISBN=&volume=13&issue=5&date=20240501&spage=1904&pages=1904-1910&title=Journal of Family Medicine and Primary Care&atitle=Immunogenicity%20of%20Covishield%20vaccine%20in%20patients%20with%20autoimmune%20rheumatic%20diseases&aulast=Vikas%20Gupta&id=DOI:10.4103/jfmpc.jfmpc_1021_23
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.f5a878090cb748128719ede264df7c89
RelevancyScore: 1020
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1020.43048095703
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vikas+Gupta%22">Vikas Gupta</searchLink><br /><searchLink fieldCode="AR" term="%22Vikram+Kumar+Gupta%22">Vikram Kumar Gupta</searchLink><br /><searchLink fieldCode="AR" term="%22Navjot+Kaur+Bajwa%22">Navjot Kaur Bajwa</searchLink><br /><searchLink fieldCode="AR" term="%22Ashi+Sachdeva%22">Ashi Sachdeva</searchLink><br /><searchLink fieldCode="AR" term="%22Rupali+Garg%22">Rupali Garg</searchLink><br /><searchLink fieldCode="AR" term="%22Abhra+Ghosh%22">Abhra Ghosh</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Journal of Family Medicine and Primary Care, Vol 13, Iss 5, Pp 1904-1910 (2024)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Wolters Kluwer Medknow Publications, 2024.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2024
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Medicine
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22autoimmune+rheumatic+diseases%22">autoimmune rheumatic diseases</searchLink><br /><searchLink fieldCode="DE" term="%22covid-19%22">covid-19</searchLink><br /><searchLink fieldCode="DE" term="%22covishield%22">covishield</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Introduction: The Coronavirus disease 2019 (COVID-19) pandemic has been the biggest threat to humankind during the last 3 years. It has caused the loss of more than 6.9 million precious lives across the world. The only method by which the massacre could be stopped was by mass vaccination or mass immunization. The patients suffering from autoimmune rheumatic disorders (AIRDs) and treated with immunosuppressants were the high-priority candidates for vaccination. However, the data regarding the efficacy of COVID-19 vaccines in this group of patients are very less. Hence, this study was planned to study the immunogenicity of Covishield in patients with AIRDs attending the rheumatology OPD at DMCH, Ludhiana. Materials and Methods: It was a prospective cohort study and was planned by the Department of Biochemistry and Department of Clinical Immunology and Rheumatology at Dayanand Medical College and Hospital, Ludhiana. Fifty patients with AIRDs attending the DMCH rheumatology OPD and 52 age and sex-matched healthy controls who had received two doses of Covishield vaccine were included in this study. Patients having any other immunosuppressive conditions like uncontrolled diabetes, hepatitis, malignancy or HIV were excluded. Patients who had suffered from previous laboratory-confirmed COVID-19 infection (by RT-PCR) were also excluded. Blood samples were collected following all aseptic precautions from patients and controls on the 28th day after administration of a second dose of Covishield vaccine and total antibodies to the severe acute respiratory syndrome coronavirus 2 spike (S) protein receptor binding domain was measured using Elecsys Anti-SARS-CoV-2 S kit from Roche. Results: It was observed that no significant difference was there in antibody titre between cases and controls (6213 ± 4418 vs. 8331 ± 7979, P = 0.1022). It was also observed that no statistically significant difference in antibody titre in cases without prednisolone and those taking treatment with prednisolone was found (P = 0.7058). A similar observation was found in terms of methotrexate also (P = 0.457). No significant difference in antibody titres was there when compared with controls (for prednisolone, P = 0.169, for methotrexate, P = 0.078). We found that only the patients receiving mycophenolate mofetil showed a statistically significant decrease in antibody titre in comparison to healthy controls (P = 0.03). Our study showed no statistically significant difference in antibody titres between patients suffering from different AIRDs. Conclusion: Our study supplements the fact that patients with AIRDs in India can receive Covishield as the primary vaccine against COVID-19 without concerns regarding decreased immunogenicity or increased adverse effects.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2249-4863<br />2278-7135
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://journals.lww.com/10.4103/jfmpc.jfmpc_1021_23; https://doaj.org/toc/2249-4863; https://doaj.org/toc/2278-7135
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.4103/jfmpc.jfmpc_1021_23
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/f5a878090cb748128719ede264df7c89" linkWindow="_blank">https://doaj.org/article/f5a878090cb748128719ede264df7c89</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.f5a878090cb748128719ede264df7c89
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f5a878090cb748128719ede264df7c89
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4103/jfmpc.jfmpc_1021_23
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1904
    Subjects:
      – SubjectFull: autoimmune rheumatic diseases
        Type: general
      – SubjectFull: covid-19
        Type: general
      – SubjectFull: covishield
        Type: general
      – SubjectFull: Medicine
        Type: general
    Titles:
      – TitleFull: Immunogenicity of Covishield vaccine in patients with autoimmune rheumatic diseases
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vikas Gupta
      – PersonEntity:
          Name:
            NameFull: Vikram Kumar Gupta
      – PersonEntity:
          Name:
            NameFull: Navjot Kaur Bajwa
      – PersonEntity:
          Name:
            NameFull: Ashi Sachdeva
      – PersonEntity:
          Name:
            NameFull: Rupali Garg
      – PersonEntity:
          Name:
            NameFull: Abhra Ghosh
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 22494863
            – Type: issn-print
              Value: 22787135
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of Family Medicine and Primary Care
              Type: main
ResultId 1